Outcomes of the Targeted Therapy Vismodegib in Patients With Periocular Basal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmic Plastic and Reconstructive Surgery
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Review of Targeted Therapy, Vismodegib, for the Treatment of Periocular Basal Cell Carcinoma
Ophthalmic Plast Reconstr Surg 2024 Jan 01;40(1)1-10, T Singalavanija, KS Ceylanoglu, S Juntipwong, BG Beser, VM Elner, FP Worden, H DemirciFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.